BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 187008)

  • 1. Functional and ultrastructural studies of the effects of human interferon on cell membranes of in vitro cultured cells.
    Degré M; Hovig T
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):347-58. PubMed ID: 187008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism in action between mouse or human interferon and platelet growth factor.
    Inglot AD; Oleszak E; Kisielow B
    Arch Virol; 1980; 63(3-4):291-6. PubMed ID: 6243926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of bovine interferons on primate cells.
    Tovey MG; Bandu MT; Begon-Lours J; Brouty-Boyé D; Gresser I
    J Gen Virol; 1977 Aug; 36(2):341-4. PubMed ID: 197203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon on cell and virus growth in transformed human cell lines.
    Fuse TK; Morinaga N
    J Gen Virol; 1976 Oct; 33(1):7-15. PubMed ID: 185329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
    Ito Y; Montagnier L
    Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the suppression of cell and virus growth in transformed human cells of leukocyte and fibroblast interferon.
    Kuwata T; Fuse A; Suzuki N; Morinaga N
    J Gen Virol; 1979 May; 43(2):435-9. PubMed ID: 225426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ouabain on the anticellular and antiviral activities of human and mouse interferon.
    Kuwata T; Fuse A; Morinaga N
    J Gen Virol; 1977 Mar; 34(3):537-40. PubMed ID: 192839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-mediated increased lysis of L-cells by vesicular stomatitis virus.
    Katz LJ; Lee SH; Rozee KR
    Can J Microbiol; 1974 Aug; 20(8):1077-83. PubMed ID: 4371530
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiproliferative and antiviral activities of human leukocyte interferons.
    Evinger M; Rubinstein M; Pestka S
    Arch Biochem Biophys; 1981 Aug; 210(1):319-29. PubMed ID: 6170263
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of a subspecies of mouse interferon cross-reactive on human cells and antigenically related to human leukocyte interferon.
    Stewart WE; Havell EA
    Virology; 1980 Feb; 101(1):315-8. PubMed ID: 6243831
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon.
    Kuwata T; Fuse A; Morinaga N
    J Gen Virol; 1977 Oct; 37(1):195-8. PubMed ID: 199703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell killing by viruses. III. The interferon system and inhibition of cell killing by vesicular stomatitis virus.
    Marcus PI; Sekellick MJ
    Virology; 1976 Feb; 69(2):378-93. PubMed ID: 176779
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the joint effect of interferon and histone on the cytopathic effect of vesicular stomatitis virus].
    Balandin IG; Diuĭsalieva RG; Kol'tsov VD; Lushnikov AA
    Vopr Virusol; 1968; 13(5):630. PubMed ID: 4303598
    [No Abstract]   [Full Text] [Related]  

  • 14. Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro.
    Edelman R; Wheelock EF
    J Virol; 1967 Dec; 1(6):1139-49. PubMed ID: 4316248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of interferon action: cloned human leukocyte interferons induce protein kinase and inhibit vesicular stomatitis virus but not reovirus replication in human amnion cells.
    Samuel CE; Knutson GS
    Virology; 1981 Oct; 114(1):302-6. PubMed ID: 6169197
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
    Mentkevich LM; Zhdanova LV; Meshkova EN
    Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of vesicular stomatitis virus in interferon-treated cell cultures.
    Thacore HR; Youngner JS
    Virology; 1975 Feb; 63(2):345-51. PubMed ID: 163524
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral and non-antiviral activity of highly purified interferon.
    Stewart WE; DeClercq E; De Somer P; Berg K; Ogburn CA; Paucker K
    Nat New Biol; 1973 Dec; 246(153):141-3. PubMed ID: 4357391
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological properties of human leukocyte interferon components.
    Paucker K; Dalton BJ; Törmä ET; Ogburn CA
    J Gen Virol; 1977 May; 35(2):341-51. PubMed ID: 69014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [More rapid method of microtitration of murine interferons by retarding the cytopathogenic effect of vesicular stomatitis virus].
    Pavlushina SV; Orlova TG
    Vopr Virusol; 1981; (2):242-3. PubMed ID: 6168118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.